HOPKINTON, Mass., June 25 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, hosted its 2010 annual Customers Owners Group (COG 2010) meeting on June 9 and 10. This thought-leadership conference is focused on sharing knowledge, insights, and techniques that accelerate the drug discovery and development process, leading to the next generation of breakthrough diagnostics and therapies.
Next Generation Sequencing pioneer Dr. George Church of Harvard Medical School kicked off COG 2010 with a keynote presentation focused on how technological advances in sequencing, coupled with a deeper understanding of the interpretation and clinical utility of genomic data, will revolutionize the healthcare industry.
Kevin Hrusovsky, president and chief executive officer of Caliper, concluded the meeting with a keynote presentation illustrating how next generation tools will revolutionize medicine. He challenged participants to set goals for themselves and their labs to utilize these tools to increase life expectancy by 10 years by 2020 while controlling healthcare system costs, and to find cures for cancer and heart disease, two leading causes of death in the U.S. Hrusovsky's vision focuses on three key diagnostic and three key therapeutic themes that will substantially revolutionize medicine. Genome sequencing, biomarkers/MDx, and non-invasive imaging are enabling diagnostic tools that can be deployed both to accelerate preclinical research and to provide faster, more accurate analysis of patient con
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved